Skip to Content
Merck

Tuning payload delivery in tumour cylindroids using gold nanoparticles.

Nature nanotechnology (2010-04-13)
Byoungjin Kim, Gang Han, Bhushan J Toley, Chae-Kyu Kim, Vincent M Rotello, Neil S Forbes
ABSTRACT

Nanoparticles have great potential as controllable drug delivery vehicles because of their size and modular functionality. Timing and location are important parameters when optimizing nanoparticles for delivery of chemotherapeutics. Here, we show that gold nanoparticles carrying either fluorescein or doxorubicin molecules move and localize differently in an in vitro three-dimensional model of tumour tissue, depending on whether the nanoparticles are positively or negatively charged. Fluorescence microscopy and mathematical modelling show that uptake, not diffusion, is the dominant mechanism in particle delivery. Our results indicate that positive particles may be more effective for drug delivery because they are taken up to a greater extent by proliferating cells. Negative particles, which diffuse more quickly, may perform better when delivering drugs deep into tissues. An understanding of how surface charge can control tissue penetration and drug release may overcome some of the current limitations in drug delivery.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Gold nanorods, 10 nm diameter, Cy3 and streptavidin functionalized, powder
Sigma-Aldrich
Gold nanorods, 10 nm diameter, Cy3 and methyl functionalized, powder
Sigma-Aldrich
Gold nanorods, 10 nm diameter, Cy3 and maleimide functionalized, powder
Sigma-Aldrich
Gold nanorods, 25 nm diameter, FITC and streptavidin functionalized, powder
Sigma-Aldrich
Gold nanorods, 25 nm diameter, FITC and amine functionalized, powder
Sigma-Aldrich
Gold nanorods, 25 nm diameter, FITC and methyl functionalized, powder
Sigma-Aldrich
Gold nanorods, 10 nm diameter, Cy3 and azide functionalized, powder
Sigma-Aldrich
Gold nanorods, 25 nm diameter, FITC and azide functionalized, powder
Sigma-Aldrich
Gold nanorods, 10 nm diameter, Cy3 and NHS functionalized, powder
Sigma-Aldrich
Gold nanorods, 10 nm diameter, Cy3 and amine functionalized, powder
Sigma-Aldrich
Gold nanorods, 25 nm diameter, FITC and biotin functionalized, powder
Sigma-Aldrich
Gold nanorods, 25 nm diameter, FITC and maleimide functionalized, powder
Sigma-Aldrich
Gold nanorods, 25 nm diameter, FITC and protein A functionalized, powder
Sigma-Aldrich
Gold nanorods, 25 nm diameter, FITC and NHS functionalized, powder
Sigma-Aldrich
Gold nanorods, 10 nm diameter, Cy3 and protein A functionalized, powder
Sigma-Aldrich
Gold nanorods, 10 nm diameter, Cy3 and carboxyl functionalized, powder
Sigma-Aldrich
Gold nanorods, 25 nm diameter, FITC and carboxyl functionalized, powder
Sigma-Aldrich
Gold nanorods, 10nm diameter, Cy3 and biotin functionalized, powder
Sigma-Aldrich
Gold nanospheres, 15 nm diameter, Cy3 and streptavidin functionalized, powder
Sigma-Aldrich
Gold nanospheres, 15 nm, Cy3 and azide functionalized, powder
Sigma-Aldrich
Gold nanospheres, 100 nm, FITC and carboxyl functionalized, powder
Sigma-Aldrich
Gold nanospheres, 100 nm, FITC and maleimide functionalized, powder
Sigma-Aldrich
Gold nanospheres, 100 nm, FITC and methyl functionalized, powder
Sigma-Aldrich
Gold nanospheres, 100 nm, FITC and NHS functionalized, powder
Sigma-Aldrich
Gold nanospheres, 100 nm, FITC and streptavidin functionalized, powder
Sigma-Aldrich
Gold nanospheres, 15 nm, Cy3 and NHS functionalized, powder
Sigma-Aldrich
Gold nanospheres, 100 nm, FITC and biotin functionalized, powder
Sigma-Aldrich
Gold nanospheres, 15 nm, Cy3 and maleimide functionalized, powder
Sigma-Aldrich
Gold nanospheres, 15 nm, Cy3 and methyl functionalized, powder
Sigma-Aldrich
Gold nanospheres, 15 nm, Cy3 and protein A functionalized, powder